Author:
Hahn Andreas,Praetorius Susanne,Karabul Nesrin,Dießel Johanna,Schmidt Dorle,Motz Reinald,Haase Claudia,Baethmann Martina,Hennermann Julia B.,Smitka Martin,Santer René,Muschol Nicole,Meyer Ann,Marquardt Thorsten,Huemer Martina,Thiels Charlotte,Rohrbach Marianne,Seyfullah Gökce,Mengel Eugen
Publisher
Springer Berlin Heidelberg
Reference20 articles.
1. Amalfitano A, Bengur AR, Morse RP et al (2001) Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 3:132–138
2. Banugaria SG, Prater SN, Ng YK et al (2011) The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease. Genet Med 13:729–736
3. Chakrapani A, Vellodi A, Robinson P, Jones S, Wraith JE (2010) Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience. J Inherit Metab Dis 33:747–750
4. Hahn A, Hennermann JB, Marquardt T et al (2012) M. Pompe im Kindesalter: Aktueller Stand der Diagnostik und Therapie. Monatsschr Kinderheilkd 160:1243–1250
5. Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In: Scriver C, Beaudet A, Valle D, Sly W (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3389–3420
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献